Heba Alkhatabi
Papers
2
Total Citations
19
H-Index
2
About
Dr. Heba Alkhatabi is a pioneering researcher at the intersection of tissue engineering, hematological oncology, and neuropharmacology. Her work centers on developing advanced 3D *in vitro* models using robotic bioprinting to recapitulate complex human microenvironments. Her most significant contribution is the fabrication of a three-dimensional bone marrow niche-like model for Acute Myeloid Leukemia (AML), created through an automated, controlled robotic multicellular bioprinting system (2023, 15 citations). This breakthrough provides a robust preclinical platform to study disease relapse and resistance mechanisms, addressing a critical gap in hematological cancer research. Dr. Alkhatabi has also applied her bioprinting expertise to neurobiology, investigating the effects of pregabalin on neuronal development using ultrashort self-assembling peptides and high-throughput 3D cultures (2024, 4 citations). By enabling the assessment of drug safety during critical developmental stages, her work has implications for both oncology and prenatal pharmacology. Through these innovative, high-fidelity models, Dr. Alkhatabi is advancing personalized medicine and reducing reliance on animal testing, establishing herself as a leader in the next generation of disease modeling.
Research Focus
Key Achievements
Top Papers
- 1
- 2